Spots Global Cancer Trial Database for A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing Treatment
Official Title: A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing Treatment
Study ID: NCT01134640
Conditions
Interventions
Study Description
Brief Summary: A post marketing surveillance, prospective study to collect safety information from 250 subjects with epidermal growth factor receptor (EGFR) expressing, KRAS wild-type metastatic colorectal cancer treated with Erbitux as final evaluable cases.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chang Gung Medical Foundation, Chiayi, , Taiwan
Chiayi Christian Hospital, Chiayi, , Taiwan
Buddhist Tzu Chi General Hospital, Hualien, , Taiwan
Chang Gung Medical Foundation, Kaohsiung, , Taiwan
Chang Gung Medical Foundation, Keelung, , Taiwan
Chang Gung Medical Foundation, LinKou, , Taiwan
Chung Shan Medical University Hospital, Taichung, , Taiwan
Taichung Veterans General Hospital, Taichung, , Taiwan
Chi Mei Medical Center, Liou Ying, Tainan, , Taiwan
Chi Mei Medical Center, Yongkang, Tainan, , Taiwan
National Cheng Kung University Hospital, Tainan, , Taiwan
Tainan Municipal Hospital, Tainan, , Taiwan
Buddhist Tzu Chi General Hospital, Taipei, , Taiwan
Mackay Memorial Hospital, Taipei, , Taiwan
Shin Kong Wu Ho-Su Memorial Hospital, Taipei, , Taiwan
Contact Details
Name: Jade Lien
Affiliation: Merck Ltd., Taiwan
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
